Table VI.
Differential CpG site information.
| Marker ID | Number of CpG sites | Number of differential CpG sites (%) | Location of differential CpG sites |
|---|---|---|---|
| FHypeMR 1 | 12 | 10 (83) | 81,219,476; 81,219,552; 81,219,603; 81,219,612; 81,219,621; 81,219,627; 81,219,638; 81,219,641; 81,219,650; 81,219,653 |
| FHypeMR 2 | 10 | 9 (90) | 50,894,456; 50,894,470; 50,894,526; 50,894,629; 50,894,651; 50,894,741; 50,894,751; 50,894,755; 50,894,806 |
| FHypeMR 3 | 15 | 9 (60) | 38,791,473; 38,791,477; 35,791,498; 38,791,661; 38,791,686; 38,791,698; 38,791,811; 38,791,885; 38,791,979 |
| FHypeMR 4 | 20 | 16 (80) | 35,261,387; 35,261,407; 35,261,449; 35,261,542; 35,261,549; 35,261,582; 35,261,618; 35,261,632; 35,261,645; 35,261,672; 35,261,682; 35,261,684; 35,261,709; 35,261,723; 35,261,745; 35,261,752 |
| FHypeMR 5 | 13 | 7 (54) | 25,205,499; 25,205,552; 25,205,563; 25,205,588; 25,205,652; 25,205,858; 25,205,967 |
| FHypoMR 1 | 7 | 5 (71) | 41,215,318; 41,215,359; 41,215,520; 41,215,533; 41,215,588 |
| FHypoMR 2 | 8 | 5 (63) | 28,517,272; 28,517,282; 28,517,310; 28,517,324; 28,517,574 |
| FHypoMR 3 | 13 | 8 (62) | 132,312,111; 132,312,156; 132,312,241; 132,312,275; 132,312,279; 132,312,289; 132,312,308; 132,312,437 |
| FHypoMR 4 | 13 | 8 (62) | 10,194,426; 10,194,449; 10,194,458; 10,194,502; 10,194,589; 10,194,644; 10,194,659; 10,194,685 |
| FHypoMR 5 | 6 | 4 (67) | 6,267,635; 6,267,782; 6,267,854; 6,267,909 |
| FHypoMR 6 | 6 | 6 (100) | 72,528,064; 72,528,126; 72,528,131; 72,528,261; 72,528,273; 72,528,385 |
CpG, C-phosphate-G; FHypeMR, fetus hypermethylation regions; FHypoMR, fetus hypomethylation regions.